bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

 
  Other news for:
Substance-Related Disorders
Substance-Related Disorders
Street Drugs
Genetics
 Resources from HONselect
Gene May Help Guide Black Patients' Opioid Addiction Treatment
Finding suggests they may need higher doses of methadone

By Robert Preidt

MONDAY, Jan. 23, 2017 (HealthDay News) -- Researchers say they've found a genetic variant associated with opioid addiction, and it might lead to personalized treatment for the condition.

Specifically, the variant was found in black Americans affecting the gene OPRM1, which is responsible for the way opioids affect the brain. Researchers at Yale University said this may identify which blacks might require higher doses of methadone. Methadone is an effective treatment for people addicted to heroin.

Proper methadone dosing is critical. Too high a dose can cause sedation and dangerous breathing difficulties, while too low of a dose can lead to relapse, the researchers said in background notes.

"Opioid addiction has become a national epidemic, and improving the effectiveness of medical therapies has to be a priority," study lead author Andrew Smith said in a university news release. Smith is a student in the M.D./Ph.D. program.

The researchers also said they've found that the same gene variant can predict the morphine dose required for effective pain control for black children undergoing surgery.

"We found specific gene effects in people with African ancestry, an understudied population," said study senior author Joel Gelernter, a professor of psychiatry, genetics and neuroscience at Yale.

The researchers didn't find these gene effects in people of European ancestry who had methadone treatment.

Smith and Gelernter said follow-up studies are needed to confirm the effects they saw in their study.

The findings were published Jan. 24 in the journal Molecular Psychiatry.

More information

The U.S. National Institute on Drug Abuse has more on opioids.

SOURCE: Yale University, news release, Jan. 24, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=718737

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Therapeutics
Research Personnel
Methadone
Substance-Related Disorders
Lead
Psychiatry
Follow-Up Studies
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact